German billionaire Dietmar Hopp is the biggest shareholder of CureVac, a Berlin-based company ... [+] working on a coronavirus vaccine. (Photo by Thomas Lohnes/Getty Images) Getty ImagesOne of Germany’s wealthiest software tycoons is the biggest shareholder in CureVac, a company racing to develop a coronavirus vaccine. Two German billionaire biotech investors are also behind BioNTech, which announced Monday it’s developing a vaccine. As the race to develop a coronavirus vaccine intensifies, one player—German drugmaker CureVac—is backed by particularly deep pockets. BioNTech, a publicly-traded German company backed by billionaire twins Thomas and Andreas Struengmann, announced on Monday its own vaccine candidate to help prevent the coronavirus.

Source: Forbes March 16, 2020 23:37 UTC